APA

Tensen C. P., Flier J., Van Der Raaij-Helmer E. M., Sampat-Sardjoepersad S., Van Der Schors R. C., Leurs R., Scheper R. J., Boorsma D. M. & Willemze R. (19990618). Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3). : The Journal of investigative dermatology.

Chicago

Tensen C P, Flier J, Van Der Raaij-Helmer E M, Sampat-Sardjoepersad S, Van Der Schors R C, Leurs R, Scheper R J, Boorsma D M and Willemze R. 19990618. Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3). : The Journal of investigative dermatology.

Harvard

Tensen C. P., Flier J., Van Der Raaij-Helmer E. M., Sampat-Sardjoepersad S., Van Der Schors R. C., Leurs R., Scheper R. J., Boorsma D. M. and Willemze R. (19990618). Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3). : The Journal of investigative dermatology.

MLA

Tensen C P, Flier J, Van Der Raaij-Helmer E M, Sampat-Sardjoepersad S, Van Der Schors R C, Leurs R, Scheper R J, Boorsma D M and Willemze R. Human IP-9: A keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3). : The Journal of investigative dermatology. 19990618.